Skip to main content

Table 4 Sex hormone levels and ovarian function in patients pre- and post-radiotherapy

From: Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy

CharacteristicsPre-radiotherapyThree months post-radiotherapyOne-year post-radiotherapy
E2, pg/mL138.68 ± 90.9168.75 ± 98.77*106.85 ± 126.46&
FSH, mIU/mL7.13 ± 6.4055.25 ± 43.35*33.14 ± 40.58&
LH, mIU/mL9.35 ± 9.6732.09 ± 24.49*20.02 ± 23.62&
Normal ovarian function, case (rate)77(100%)34 (44.3%)56(72.7%) #
  1. *Student’s t-test, Comparison of sex hormone levels with pre-radiotherapy. P < 0.01
  2. &Student’s t-test, Comparison of sex hormone levels with 3 months post-radiotherapy. P < 0.05
  3. #χ2 test, Comparison of cases of normal ovarian function with 3 months post-radiotherapy. P < 0.01